文献速递糖尿病

多基因风险评分预测糖尿病并发症及其对强化血压和血糖控制的反应

Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control.
PubMed 文献 · Diabetologia · 2021-07-06

研究开发了整合10个加权多基因风险评分(10 wPRS,含598个SNP)的多PRS模型,在ADVANCE研究4098例和UK Biobank 17604例2型糖尿病患者中预测微血管和大血管结局。模型识别出ADVANCE中风险最高的30%参与者,其主要微血管和大血管事件风险分别增加3.1倍,心血管死亡风险增加4.4倍。在ADVANCE总体中,强化血压和血糖控制使心血管死亡降低24%,而模型识别的高风险组中死亡率降低47%,低风险组无明显效果;高风险组5年预防一例心血管死亡的需治疗人数为12。

要点

  • 多PRS模型可对2型糖尿病患者的并发症风险进行分层。
  • 高风险组从强化血压和血糖控制中获益更大,心血管死亡降低47%。
  • 高风险组5年预防一例心血管死亡的需治疗人数为12。

核心结论

  • 新型多PRS模型能根据并发症风险对2型糖尿病患者进行分层,有助于早期靶向识别将从强化治疗中获益更大的人群。

研究设计与样本

  • 研究开发了结合10个加权PRS(10 wPRS,含598个SNP)的多PRS模型,并在ADVANCE研究4098例参与者和UK Biobank 17604例2型糖尿病患者中验证。

主要发现

  • 模型在不同队列中对心血管和肾脏并发症显示出相似的预测性能。
  • 模型识别出ADVANCE中风险最高的30%参与者,其主要微血管和大血管事件风险平均增加3.1倍(p = 6.3 × 10-21 和 p = 9.6 × 10-31),心血管死亡风险增加4.4倍(p = 6.8 × 10-33)。
  • ADVANCE总体中强化血压和血糖控制使心血管死亡降低24%,而模型识别的高风险组中死亡率降低47%,低风险组无明显效果。
  • 高风险组绝对风险降低最大,5年预防一例心血管死亡的需治疗人数为12。

临床怎么用

  • 可利用多PRS模型对2型糖尿病患者进行并发症风险分层,识别高风险个体并优先给予强化血压和血糖控制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Type 2 diabetes increases the risk of cardiovascular and renal complications, but early risk prediction could lead to timely intervention and better outcomes. Genetic information can be used to enable early detection of risk. METHODS: We developed a multi-polygenic risk score (multiPRS) that combines ten weighted PRSs (10 wPRS) composed of 598 SNPs associated with main risk factors and outcomes of type 2 diabetes, derived from summary statistics data of genome-wide association studies. The 10 wPRS, first principal component of ethnicity, sex, age at onset and diabetes duration were included into one logistic regression model to predict micro- and macrovascular outcomes in 4098 participants in the ADVANCE study and 17,604 individuals with type 2 diabetes in the UK Biobank study. RESULTS: The model showed a similar predictive performance for cardiovascular and renal complications in different cohorts. It identified the top 30% of ADVANCE participants with a mean of 3.1-fold increased risk of major micro- and macrovascular events (p = 6.3 × 10-21 and p = 9.6 × 10-31, respectively) and a 4.4-fold (p = 6.8 × 10-33) higher risk of cardiovascular death. While in ADVANCE overall, combined intensive blood pressure and glucose control decreased cardiovascular death by 24%, the model identified a high-risk group in whom it decreased the mortality rate by 47%, and a low-risk group in whom it had no discernible effect. High-risk individuals had the greatest absolute risk reduction with a number needed to treat of 12 to prevent one cardiovascular death over 5 years. CONCLUSIONS/INTERPRETATION: This novel multiPRS model stratified individuals with type 2 diabetes according to risk of complications and helped to target earlier those who would receive greater benefit from intensive therapy.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Tremblay J, Haloui M, Attaoua R, et al. Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control. Diabetologia. 2021. PMID: 34226943. doi:10.1007/s00125-021-05491-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。